MARGARET BRITT: Open Payments
NPI 1033741590 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 38 payments from 12 companies in 2025. Trend: 2023 $1,414 · 2024 $799 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $110 |
| Amgen Inc. | 5 | $99 |
| Alnylam Pharmaceuticals Inc. | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| SCPHARMACEUTICALS INC. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Novo Nordisk Inc | 2 | $55 |
| PFIZER INC. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: REPATHA, VERQUVO, JARDIANCE, Kerendia, AMVUTTRA, FUROSCIX, Wegovy, LEQVIO.
Industry payments across SC — which companies pay providers there.
